Inventor · disambiguated record
Alan S. Harris
Also filed as: HARRIS ALAN S
12 granted patents·5 pending applications·410 citations·filing 2006–2024
94Inventor score
Files withNOVARTIS AG8BRISTOL MYERS SQUIBB CO5CHEN YAN2ADNEXUS A BRISTOL MYERS SQUIBB1DRANOFF GLENN1
Top patents by PatentIndex Score
17 records- 0198US10981990B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2020·Granted Apr 20, 2021·11 cites·30 claims
- 0298US9605070B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2015·Granted Mar 28, 2017·67 cites·85 claims
- 0398US7858739B2Inhibitors of type 2 vascular endothelial growth factor receptorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 28, 2010·84 cites·79 claims
- 0497US8324362B2Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptorsCHEN YAN·Filed 2010·Granted Dec 4, 2012·58 cites·10 claims
- 0597US7847062B2Pharmacokinetic modulation and compositions for modified FN3 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 7, 2010·77 cites·15 claims
- 0696US9862758B2Inhibitors of type 2 vascular endothelial growth factor receptorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 9, 2018·20 cites·22 claims
- 0796US8609613B2Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptidesCHEN YAN·Filed 2012·Granted Dec 17, 2013·36 cites·20 claims
- 0895US11155620B2Method of detecting TIM-3 using antibody molecules to TIM-3NOVARTIS AG·Filed 2019·Granted Oct 26, 2021·6 cites·20 claims
- 0995US9328157B2Inhibitors of type 2 vascular endothelial growth factor receptorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 3, 2016·26 cites·7 claims
- 1093US10472419B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Nov 12, 2019·12 cites·57 claims
- 1193US9884913B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Feb 6, 2018·12 cites·30 claims
- 1283US10995131B2Libraries of modified fibronectin type III tenth domain-containing polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 4, 2021·1 cites·14 claims
- 1382US2025213684A1Combination therapies comprising antibody molecules to tim-3NOVARTIS AG·Filed 2024·Application pending·0 cites
- 1478US2022185883A1Method of detecting tim-3 using antibody molecules to tim-3NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1570US2022133889A1Combination therapies comprising antibody molecules to tim-3NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1656US2018207273A1Combination therapies comprising antibody molecules to tim-3DRANOFF GLENN·Filed 2016·Application pending·0 cites
- 1747US2008220049A1Compositions and methods for intraocular delivery of fibronectin scaffold domain proteinsADNEXUS A BRISTOL MYERS SQUIBB·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alan S. Harris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →